These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31678635)

  • 1. Therapeutic efficacy of mesenchymal stromal cells and secretome in pulmonary arterial hypertension: A systematic review and meta-analysis.
    Muhammad SA; Abbas AY; Saidu Y; Fakurazi S; Bilbis LS
    Biochimie; 2020 Jan; 168():156-168. PubMed ID: 31678635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of stem cell therapy for pulmonary arterial hypertension: a systematic review and meta-analysis of preclinical studies.
    Ding XF; Liang HY; Yuan B; Li LF; Wang T; Kan QC; Wang LX; Sun TW
    Stem Cell Res Ther; 2019 Feb; 10(1):55. PubMed ID: 30760312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review.
    Suen CM; Stewart DJ; Montroy J; Welsh C; Levac B; Wesch N; Zhai A; Fergusson D; McIntyre L; Lalu MM
    Stem Cell Res Ther; 2019 Mar; 10(1):75. PubMed ID: 30841915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension.
    Braga CL; Santos RT; da Silva CM; de Novaes Rocha N; Felix NS; Medeiros M; Melo MM; Silva JD; Teixeira DE; Neves CC; Rocco PRM; Cruz FF; Silva PL
    Life Sci; 2023 Sep; 329():121988. PubMed ID: 37517581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem/stromal cell therapy for pulmonary arterial hypertension: Comprehensive review of preclinical studies.
    Fukumitsu M; Suzuki K
    J Cardiol; 2019 Oct; 74(4):304-312. PubMed ID: 31109735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of stem cells and secretome in articular cartilage regeneration: a systematic review and meta-analysis.
    Muhammad SA; Nordin N; Mehat MZ; Fakurazi S
    Cell Tissue Res; 2019 Feb; 375(2):329-344. PubMed ID: 30084022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension.
    Oh S; Jang AY; Chae S; Choi S; Moon J; Kim M; Spiekerkoetter E; Zamanian RT; Yang PC; Hwang D; Byun K; Chung WJ
    Sci Rep; 2021 Jan; 11(1):2012. PubMed ID: 33479312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose-derived mesenchymal stromal cells improve hemodynamic function in pulmonary arterial hypertension: identification of microRNAs implicated in modulating endothelial function.
    Wang P; Zhang C; Li J; Luo L; Zhang S; Dong F; Tang Z; Ni S
    Cytotherapy; 2019 Apr; 21(4):416-427. PubMed ID: 30904330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
    de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
    Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol.
    Suen CM; Zhai A; Lalu MM; Welsh C; Levac BM; Fergusson D; McIntyre L; Stewart DJ
    Syst Rev; 2016 May; 5():89. PubMed ID: 27225668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis.
    Farmakis IT; Vazakidis P; Doundoulakis I; Arvanitaki A; Zafeiropoulos S; Boutou A; Karvounis H; Giannakoulas G
    Pulm Pharmacol Ther; 2021 Jun; 68():102036. PubMed ID: 33979684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system.
    Liu C; Jiang XM; Zhang J; Li B; Li J; Xie DJ; Hu ZY
    BMC Cardiovasc Disord; 2016 Oct; 16(1):192. PubMed ID: 27724864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Dose and Timing of Umbilical Stem Cells Treatment in Pulmonary Arterial Hypertensive Rats.
    Lee H; Kim KC; Choi SJ; Hong YM
    Yonsei Med J; 2017 May; 58(3):570-580. PubMed ID: 28332363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in rats.
    Chen JY; An R; Liu ZJ; Wang JJ; Chen SZ; Hong MM; Liu JH; Xiao MY; Chen YF
    Acta Pharmacol Sin; 2014 Sep; 35(9):1121-8. PubMed ID: 25088001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension.
    Liang OD; Mitsialis SA; Chang MS; Vergadi E; Lee C; Aslam M; Fernandez-Gonzalez A; Liu X; Baveja R; Kourembanas S
    Stem Cells; 2011 Jan; 29(1):99-107. PubMed ID: 20957739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Tongxinluo on pulmonary hypertension and pulmonary vascular remodeling in rats exposed to a low pressure hypoxic environment.
    Wang Y; Ma TT; Gao NN; Zhou XL; Jiang H; Guo R; Jia LN; Chang H; Gao Y; Gao ZM; Pan L
    J Ethnopharmacol; 2016 Dec; 194():668-673. PubMed ID: 27737815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
    Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
    J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mesenchymal stem cells attenuate pulmonary hypertension induced by prenatal lipopolysaccharide treatment in rats.
    Chou HC; Lin W; Chen CM
    Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):906-14. PubMed ID: 27273502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.